Aaron Sonshine

6 days ago | jdsupra.com | Kim Lawton |Aaron Sonshine

The Bloom Burton & Co. Healthcare Investor Conference (BBHIC), held in Toronto this week, drew over 1,500 global participants to one of Canada's leading events for healthcare investment and innovation. The conference brought together leading Canadian healthcare companies, institutional investors and international industry leaders for in-depth discussions on emerging trends and strategic opportunities in the sector.

1 week ago | bennettjones.com | Aaron Sonshine |Kim Lawton

The Bloom Burton & Co. Healthcare Investor Conference (BBHIC), held in Toronto this week, drew over 1,500 global participants to one of Canada's leading events for healthcare investment and innovation. The conference brought together leading Canadian healthcare companies, institutional investors and international industry leaders for in-depth discussions on emerging trends and strategic opportunities in the sector.

Jun 20, 2024 | mondaq.com | Aaron Sonshine

Aaron Sonshine comments on positive deal-making trends in technology and healthcare in Lexpert's special look at the sectors. "I'd say, overall, the situation is improving," says Aaron. "Look no further than the United States and Canadian stock market indices—you see the NASDAQ, Dow, and even the TSX hovering around historic highs.

Jun 18, 2024 | bennettjones.com | Aaron Sonshine

Aaron Sonshine comments on positive deal-making trends in technology and healthcare in Lexpert’s special look at the sectors. “I’d say, overall, the situation is improving,” says Aaron. “Look no further than the United States and Canadian stock market indices—you see the NASDAQ, Dow, and even the TSX hovering around historic highs.

May 8, 2024 | mondaq.com | Aaron Sonshine |Kim Lawton

It was another record-breaking year for the annual Bloom Burton & Co. Healthcare Investor Conference (BBHIC) in Toronto. The event brought together premier healthcare companies and investors from Canada and around the world. At the conference, a high-caliber panel shared their insights on investing in R&D-stage healthcare companies—with thought-provoking views from Khosla Ventures, GordonMD Global Investments, Matrix Capital Management and J & J Innovation.